Will the FDA approve a weight-loss drug with a label indicating a lower incidence of severe gastrointestinal side effects (e.g., less than 15% incidence of severe nausea/vomiting) than current market leaders (Ozempic/Wegovy, Zepbound) by December 31, 2026?
Resolves: YES if the U.S. Food and Drug Administration (FDA) grants approval for a new prescription weight-loss medication whose official prescribing information (label) explicitly states a lower incidence of severe gastrointestinal adverse events (e.g., nausea, vomiting, diarrhea) in its clinical trials compared to the reported rates for semaglutide (Wegovy/Ozempic) or tirzepatide (Zepbound) in their respective FDA-approved labels. NO otherwise.
Will the FDA approve a weight-loss drug with a label indicating a low…
Market overview
Regulatory approval requires robust clinical data demonstrating both efficacy and an acceptable safety profile. While drug development is lengthy, the intense competition and focus on side effect mitigation suggest that a drug with a demonstrably better tolerability profile could gain approval within this timeframe.
Legal prediction market
- Implied probability (Yes)
- 30%
- Closes
- 2026-12-31
About this prediction
How this resolves
YES if the U.S. Food and Drug Administration (FDA) grants approval for a new prescription weight-loss medication whose official prescribing information (label) explicitly states a lower incidence of severe gastrointestinal adverse events (e.g., nausea, vomiting, diarrhea) in its clinical trials compared to the reported rates for semaglutide (Wegovy/Ozempic) or tirzepatide (Zepbound) in their respective FDA-approved labels. NO otherwise.
Source: user-generated
More Legal markets
- Will Baviskar's trading accounts be permanently restricted by November 25, 2026? — 95% Yes
- Will Ichcoin Tech Corp. settle with the SEC within 90 days? — 75% Yes
- Will any individual respondent settle with the SEC before year-end 2026? — 30% Yes
- Will the SEC announce a freeze on Ferder's personal assets by November 30, 2026? — 70% Yes
- Will Bonanza Global investors recover more than $1M by November 2026? — 25% Yes
- Will at least one respondent comply with subpoenas within 30 days of court order? — 65% Yes
- Will the court impose a civil penalty on Chavez by 2026-12-01? — 90% Yes
- SEC drops enforcement actions against major crypto exchanges within 12 months — 55% Yes